Treating status migrainosus in the emergency setting: what is the best strategy?
Authors:
- 10 September 2018
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Pharmacotherapy
- Vol. 19 (14) , 1523-1531
Abstract
Migraine is a disabling primary headache disorder with unknown exact pathomechanism. Status migrainosus (SM) is a complication of migraine (with or without aura), representing an attack that lasts for more than 72 h. There is a paucity of data published with regard to its pathomechanism and therapeutic options. The authors review the literature on SM from PubMed published between 1999 and January 2018. The authors specifically look at the therapeutic possibilities of SM in the emergency department in patients that have or have not already been treated with serotonergic agents. Additional discussion is given to the rare complications of migraine. SM is a devastating condition; therefore, the primary goal is to prevent its development with proper acute and prophylactic migraine medication. If this treatment fails, the patient should be treated in the emergency setting. Due to the severity of the condition, parenteral pharmacotherapy is recommended. However, high-quality randomized trials are lacking. The currently available data suggest the use of intravenous fluids, corticosteroids, magnesium sulfate, anticonvulsive drugs, nonsteroidal anti-inflammatory drugs, antiemetics, and serotonergic agents for the treatment of SM. Still, there is a need for personalized and causal therapy for migraine sufferers.Keywords
Funding Information
- Economic Development and Innovation Operational Program (GINOP-2.3.2-15-2016-00034)
- MTA-SZTE Neuroscience Research Group of the Hungarian Academy of Sciences
This publication has 69 references indexed in Scilit:
- Orally Inhaled Dihydroergotamine: A ReviewHeadache: The Journal of Head and Face Pain, 2013
- A randomized open-label study of sodium valproate vs sumatriptan and metoclopramide for prolonged migraine headacheThe American Journal of Emergency Medicine, 2013
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2012
- Rapid improvement of a complex migrainous episode with sodium valproate in a patient with CADASILThe Journal of Headache and Pain, 2011
- Costs associated with outpatient, emergency room and inpatient care for migraine in the USACephalalgia, 2011
- Metoclopramide for Acute Migraine: A Dose-Finding Randomized Clinical TrialAnnals of Emergency Medicine, 2011
- CADASIL presenting as status migrainosus and persisting aura without infarctionThe Journal of Headache and Pain, 2008
- Parenteral dexamethasone for acute severe migraine headache: meta-analysis of randomised controlled trials for preventing recurrenceBMJ, 2008
- Role of intravenous levetiracetam in status migrainosusThe Journal of Headache and Pain, 2007
- Pharmacokinetics and Pharmacodynamics of Systemically Administered GlucocorticoidsClinical Pharmacokinetics, 2005